The First Crispr Medicine Just Got Approved
Publisher |
WIRED
Media Type |
audio
Categories Via RSS |
Science
Publication Date |
Nov 20, 2023
Episode Duration |
00:05:43

The gene-editing therapy, called Casgevy, uses Crispr to prevent debilitating pain in patients with sickle cell disease. It also eliminates the need for regular blood transfusions in people with beta thalassemia.

Read this story here.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review